[#item_full_content] Trulieve Cannabis (TRLV) just confirmed it secured Drug Enforcement Administration registrations for its state-licensed medical marijuana dispensaries, following the federal move to classify qualifying medical cannabis as Schedule III under the Controlled Substances Act. The DEA registrations come at a time when Trulieve Cannabis has already seen positive momentum, with a 1-day share price return of 7.98% and a 90-day share price return of 24.86%. This has contributed to a 27.59% share price… 
Read More
What Just Happened With Trulieve Cannabis (TRLV) Shares?
ByPot Shop News
November 2, 2026